Related Experiment Video
Updated: Aug 2, 2025
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
20.0K
Smoking-Related Interstitial Lung Diseases.
Amarilys Alarcon-Calderon1, Robert Vassallo1, Eunhee S Yi2
1Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, 200 1st Street, Southwest, Rochester, MN 55905, USA.
Immunology and Allergy Clinics of North America
|April 13, 2023
Summary
This review covers smoking-related interstitial lung diseases (ILDs), including their causes, symptoms, diagnosis, and treatments. It also addresses incidental findings like interstitial lung abnormalities and smoking-related fibrosis.
Area of Science:
- Pulmonology
- Toxicology
- Radiology
Background:
- Smoking is a major cause of diffuse lung diseases.
- Interstitial lung diseases (ILDs) are a diverse group of lung conditions linked to tobacco use.
- These include conditions like pulmonary Langerhans cell histiocytosis and desquamative interstitial pneumonia.
Purpose of the Study:
- To review the current understanding of smoking-related interstitial lung diseases (ILDs).
- To summarize evidence on pathogenesis, clinical features, diagnosis, prognosis, and treatment.
- To discuss incidentally detected interstitial lung abnormalities and smoking-related fibrosis.
Main Methods:
- Comprehensive literature review of smoking-related ILDs.
- Analysis of current evidence on disease mechanisms and clinical presentation.
- Evaluation of diagnostic strategies and therapeutic options.
Main Results:
- Smoking-related ILDs are a heterogeneous group of lung diseases.
- Key conditions include pulmonary Langerhans cell histiocytosis, respiratory bronchiolitis-associated ILD, and others.
- Radiologic and biopsy findings, including incidental abnormalities, are discussed.
Conclusions:
- Understanding the pathogenesis and clinical spectrum of smoking-related ILDs is crucial.
- Early diagnosis and appropriate management can improve patient outcomes.
- Further research into interstitial lung abnormalities and smoking-related fibrosis is warranted.
Related Concept Videos
01:17Other Pulmonary Disorders
880
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
880
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:30Pneumonia I: Introduction
289
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
289
01:20COPD: Pathogenesis and Clinical Features
385
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
385